Exane Derivatives’s Washington Prime Group Inc. WPG Stock Holding History

Exane Derivatives’s Portfolio WPG Stock Details WPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9	Closed	-$1.05K	–	583
2015 Q2	$1.05K	Hold	9	–	–	﹤0.01%	439
2015 Q1	$1.3K	Hold	9	–	–	﹤0.01%	440
2014 Q4	$1.34K	Buy	+9	New	+$1.39K	﹤0.01%	470

Other funds holding WPG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Exane Derivatives's WPG Position: Q3 2015 in Review

Exane Derivatives sold out of Washington Prime Group Inc. (WPG) in Q3 2015, closing a stake of 9 shares — an estimated $1.05K sold.

Exane Derivatives first reported a position in WPG in Q4 2014 and held it in 3 quarters. The position peaked at $1.34K in Q4 2014. 273 funds tracked by Wall St. Rank hold WPG as of Q3 2015.

Exane Derivatives reported no remaining Washington Prime Group Inc. position as of Q3 2015 after selling out during the quarter.
Exane Derivatives sold 9 Washington Prime Group Inc. shares in Q3 2015, an estimated $1.05K.
Exane Derivatives first reported a position in Washington Prime Group Inc. in Q4 2014 and held it in 3 quarters.
Exane Derivatives's Washington Prime Group Inc. position peaked at $1.34K in Q4 2014.
273 funds tracked by Wall St. Rank held Washington Prime Group Inc. as of Q3 2015.

Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.